We are live on ! Find out more
AVNS icon

Avanos Medical
AVNS

291 hedge funds and large institutions have $1.92B invested in Avanos Medical in 2021 Q1 according to their latest regulatory filings, with 46 funds opening new positions, 60 increasing their positions, 80 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

39% more first-time investments, than exits

New positions opened: 46 | Existing positions closed: 33

4% more funds holding

Funds holding: 281 → 291 (+10)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

2.56% less ownership

Funds ownership: 94.41% → 91.85% (-2.6%)

7% less capital invested

Capital invested by funds: $2.07B → $1.92B (-$142M)

25% less repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 80

Holders
291
Holders Change
+10
Holders Change %
+3.56%
% of All Funds
5.11%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
46
Increased
60
Reduced
80
Closed
33
Calls
$1.3M
Puts
–
Net Calls
+$1.3M
Net Calls Change
+$193K

Top Buyers

1
BlackRock
BlackRock
New York
+$13.5M
2
Millennium Management
Millennium Management
New York
+$11M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$6.87M
4
TCM
Tygh Capital Management
Oregon
+$5.28M
5
JP Morgan Chase
JP Morgan Chase
New York
+$5.23M

Top Sellers

1
CIP
Champlain Investment Partners
Vermont
-$26.2M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$17.2M
3
Northern Trust
Northern Trust
Illinois
-$16.7M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$12.8M
5
CSC
Cove Street Capital
California
-$9.38M
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$245M +$13.5M +287,727 +5%
Vanguard Group
2
Vanguard Group
Pennsylvania
$196M +$6.87M +146,351 +3%
Wellington Management Group
3
Wellington Management Group
Massachusetts
$172M -$17.2M -367,042 -9%
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$141M -$12.8M -273,699 -8%
CIP
5
Champlain Investment Partners
Vermont
$127M -$26.2M -558,747 -16%
PIM
6
Paradice Investment Management
Colorado
$108M -$772K -16,449 -0.7%
Dimensional Fund Advisors
7
Dimensional Fund Advisors
Texas
$99.3M +$2.69M +57,263 +3%
Victory Capital Management
8
Victory Capital Management
Texas
$85.2M -$6.98M -148,803 -7%
RC
9
RGM Capital
Florida
$84.1M -$2.95M -62,800 -3%
State Street
10
State Street
Massachusetts
$73.8M +$931K +19,835 +1%
Macquarie Group
11
Macquarie Group
Australia
$65.2M -$1.73M -36,795 -2%
Goldman Sachs
12
Goldman Sachs
New York
$59.4M -$367K -7,828 -0.6%
Northern Trust
13
Northern Trust
Illinois
$44.9M -$16.7M -355,771 -26%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$33.4M +$2.15M +45,830 +6%
Bank of New York Mellon
15
Bank of New York Mellon
New York
$24.4M -$3.14M -66,906 -11%
Royal Bank of Canada
16
Royal Bank of Canada
Ontario, Canada
$23.5M -$1.91M -40,752 -7%
CIM
17
Confluence Investment Management
Missouri
$20.4M -$659K -14,048 -3%
Neuberger Berman Group
18
Neuberger Berman Group
New York
$20M -$1.27M -27,151 -6%
Charles Schwab
19
Charles Schwab
California
$17.4M +$171K +3,636 +0.9%
AIMCA
20
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$13M – – –
Norges Bank
21
Norges Bank
Norway
$12.9M -$4.3M -91,696 -24%
N
22
Nuveen
North Carolina
$12.7M +$2.78M +59,263 +26%
Arrowstreet Capital
23
Arrowstreet Capital
Massachusetts
$12.1M +$4.48M +95,525 +53%
Invesco
24
Invesco
Georgia
$12.1M +$2.57M +54,696 +25%
Millennium Management
25
Millennium Management
New York
$10.9M +$11M +233,780 +1,476%
1
2 3 4 5

AVNS Hedge Fund Activity: Q1 2021 in Review

291 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Avanos Medical (AVNS) for Q1 2021, worth a combined $1.92B — down 6.9% from $2.07B a quarter earlier.

Buyers outnumbered sellers: 46 funds opened new AVNS positions and 33 closed out — a net gain of 13 holders — while 60 added to existing stakes and 80 trimmed.

The largest buyer was BlackRock, adding an estimated $13.5M. The largest seller was Champlain Investment Partners, cutting an estimated $26.2M.

  • 291 institutional investors held Avanos Medical (AVNS) as of Q1 2021, up from 281 in Q4 2020.
  • Funds reported $1.92B of Avanos Medical stock for Q1 2021, down 6.9% quarter-over-quarter.
  • 46 funds opened new Avanos Medical positions in Q1 2021 and 33 closed out, a net change of +13 holders.
  • The largest Avanos Medical buyer in Q1 2021 was BlackRock, an estimated $13.5M added.
  • The largest Avanos Medical seller in Q1 2021 was Champlain Investment Partners, an estimated $26.2M sold.

Based on aggregated 13F filings for Q1 2021.